These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25737146)

  • 41. Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures.
    Ahmad S; Joseph L; Hagen F; Meis JF; Khan Z
    J Antimicrob Chemother; 2015 Feb; 70(2):412-5. PubMed ID: 25326091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Small Animal Aspergillosis and Cryptococcosis in Japan].
    Kano R
    Med Mycol J; 2017; 58(4):J121-J126. PubMed ID: 29187719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of optimum growth conditions for gliotoxin production by Aspergillus fumigatus and development of a novel method for gliotoxin detection.
    Belkacemi L; Barton RC; Hopwood V; Evans EG
    Med Mycol; 1999 Aug; 37(4):227-33. PubMed ID: 10421857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of media and temperature on gliotoxin production in Aspergillus fumigatus strains.
    Kosalec I; Pepeljnjak S; Jandrlić M
    Arh Hig Rada Toksikol; 2005 Sep; 56(3):269-73. PubMed ID: 16180613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does hydrocortisone modify the in vitro susceptibility of Aspergillus fumigatus to itraconazole and amphotericin B?
    Ramondenc I; Pinel C; Ambroise-Thomas P; Grillot R
    Med Mycol; 1998 Apr; 36(2):69-73. PubMed ID: 9776816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic and Phenotypic Heterogeneity of Clinical Isolates of the Human Pathogens
    Dos Santos RAC; Steenwyk JL; Rivero-Menendez O; Mead ME; Silva LP; Bastos RW; Alastruey-Izquierdo A; Goldman GH; Rokas A
    Front Genet; 2020; 11():459. PubMed ID: 32477406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gliotoxin effects on fungal growth: mechanisms and exploitation.
    Carberry S; Molloy E; Hammel S; O'Keeffe G; Jones GW; Kavanagh K; Doyle S
    Fungal Genet Biol; 2012 Apr; 49(4):302-12. PubMed ID: 22405895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal susceptibility of Aspergillus fumigatus clinical isolates collected from various areas in Japan.
    Kikuchi K; Watanabe A; Ito J; Oku Y; Wuren T; Taguchi H; Yarita K; Muraosa Y; Yahiro M; Yaguchi T; Kamei K
    J Infect Chemother; 2014 May; 20(5):336-8. PubMed ID: 24751235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GliA in Aspergillus fumigatus is required for its tolerance to gliotoxin and affects the amount of extracellular and intracellular gliotoxin.
    Wang DN; Toyotome T; Muraosa Y; Watanabe A; Wuren T; Bunsupa S; Aoyagi K; Yamazaki M; Takino M; Kamei K
    Med Mycol; 2014 Jul; 52(5):506-18. PubMed ID: 24847038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two cases of feline orbital aspergillosis due to Aspergillus udagawae and A. viridinutans.
    Kano R; Shibahashi A; Fujino Y; Sakai H; Mori T; Tsujimoto H; Yanai T; Hasegawa A
    J Vet Med Sci; 2013 Jan; 75(1):7-10. PubMed ID: 22878535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
    Chen J; Li H; Li R; Bu D; Wan Z
    J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.
    Lass-Flörl C; Nagl M; Speth C; Ulmer H; Dierich MP; Würzner R
    Antimicrob Agents Chemother; 2001 Jan; 45(1):124-8. PubMed ID: 11120954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of N-chlorotaurine on Aspergillus, with particular reference to destruction of secreted gliotoxin.
    Reeves EP; Nagl M; O'Keeffe J; Kelly J; Kavanagh K
    J Med Microbiol; 2006 Jul; 55(Pt 7):913-918. PubMed ID: 16772419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus.
    Torres HA; Rivero GA; Lewis RE; Hachem R; Raad II; Kontoyiannis DP
    Diagn Microbiol Infect Dis; 2003 May; 46(1):25-8. PubMed ID: 12742315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exposure of Aspergillus fumigatus to caspofungin results in the release, and de novo biosynthesis, of gliotoxin.
    Eshwika A; Kelly J; Fallon JP; Kavanagh K
    Med Mycol; 2013 Feb; 51(2):121-7. PubMed ID: 23323804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Deep-seated mycosis. Aspergillus lentulus].
    Yaguchi T
    Med Mycol J; 2015; 56(4):J137-8. PubMed ID: 26617110
    [No Abstract]   [Full Text] [Related]  

  • 57. GliZ, a transcriptional regulator of gliotoxin biosynthesis, contributes to Aspergillus fumigatus virulence.
    Bok JW; Chung D; Balajee SA; Marr KA; Andes D; Nielsen KF; Frisvad JC; Kirby KA; Keller NP
    Infect Immun; 2006 Dec; 74(12):6761-8. PubMed ID: 17030582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impairing fluoride export of Aspergillus fumigatus mitigates its voriconazole resistance.
    Binder J; Held J; Krappmann S
    Int J Antimicrob Agents; 2019 May; 53(5):689-693. PubMed ID: 30763611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid identification of Aspergillus fumigatus within the section Fumigati.
    Serrano R; Gusmão L; Amorim A; Araujo R
    BMC Microbiol; 2011 Apr; 11():82. PubMed ID: 21510879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contributions of Spore Secondary Metabolites to UV-C Protection and Virulence Vary in Different Aspergillus fumigatus Strains.
    Blachowicz A; Raffa N; Bok JW; Choera T; Knox B; Lim FY; Huttenlocher A; Wang CCC; Venkateswaran K; Keller NP
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.